All In Biotech

Drug Trial Radar · NCT07438444

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

A Phase 4, Open-Label, Single-Arm, 46-Week Study to Investigate the Safety and Efficacy With Tirzepatide in Adult Indian Participants With Either Type 2 Diabetes or Obesity

Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

344

Planned (sponsor's estimate)

Start

Feb 27, 2026

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Feb 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to measure the safety and efficacy of tirzepatide in adult participants in India who have type 2 diabetes or who have obesity or overweight without type 2 diabetes. Participation in the study will last about 46 weeks.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity
  • Overweight

Interventions

  • TirzepatideDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants with One or More Serious Adverse Events (SAE) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline through Week 46

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • B. J. Medical College & Civil Hospital

    Ahmedabad, India

  • V.S. General Hospital

    Ahmedabad, India

  • Gujarat Endocrine Center

    Ahmedabad, India

  • Jawahar Lal Nehru Medical College

    Ajmer, India

  • Motilal Nehru Medical College Hospital

    Allahabād, India

  • Lifecare Hospital and Research Centre

    Bengaluru, India

  • AIIMS, Bhubaneshwar

    Bhubaneswar, India

  • Sri Ramachandra MedicaL College & Research Institute

    Chennai, India

  • Kovai Diabetes Speciality Center and Hospital

    Coimbatore, India

  • Apollo Excelcare Hospital

    Guwahati, India

  • Osmania Medical College & Hospital

    Hyderabad, India

  • Eternal Heart Care Center and Research Institute

    Jaipur, India

  • K care Hospital

    Kanpur, India

  • Brij Medical Centre Private Limited

    Kanpur, India

  • ILS Hospitals

    Kolkata, India

  • Government Medical College, Kozhikode

    Kozhikode, India

  • Wockhardt Hospitals

    Mumbai, India

  • Shri Krishna Hrudayalaya & Critical Care Centre

    Nagpur, India

  • Sahyadri Super Speciality Hospital

    Pune, India

  • All India Institute of Medical Sciences

    Raipur, India

  • King George Hospital, Andhra Medical College

    Visakhapatnam, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.